Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Aug;190(3):1205-1212.
doi: 10.1007/s11845-020-02437-7. Epub 2020 Nov 20.

Kidney-gut crosstalk in renal disease

Affiliations
Review

Kidney-gut crosstalk in renal disease

Iara Colombo et al. Ir J Med Sci. 2021 Aug.

Abstract

Introduction: The colon has an important role in managing nitrogenous waste products, electrolytes, and mineral balance during kidney diseases. However, colonic microbiota produces uremic toxins, such as indoxyl sulfate and p-cresyl sulfate, in chronic kidney disease (CKD) patients, which due to their proinflammatory properties contribute to CKD progression. Conversely, in acute renal injury patients, intestinal microbiota could reduce inflammation by secreting short-chain fatty acids and inducing a renal protective immune response. However, since the intestines are the most frequently affected organ in advanced sepsis, colonic microbiota can also represent a negative factor for kidney health in this scenario.

Conclusion: In the present review, the main characteristics of kidney-gut crosstalk are described.

Keywords: Crosstalk; Gut; Kidney.

PubMed Disclaimer

References

    1. Muso CG (2020) Biosemiotic medicine: from an effect-based medicine to a process-based medicine. Arch Argent Pediatr 118(5):e449–e453
    1. Poesen R, Meijers B, Evenepoel P (2013) The colon: an overlooked site for therapeutics in dialysis patients. Semin Dial 26(3):323–332 - DOI
    1. Ranganathan N, Ranganathan P, Friedman EA et al (2010) Pilot study of probiotic dietary supplementation for promoting healthy kidney function in patients with chronic kidney disease. Adv Ther 27(9):634–647. https://doi.org/10.1007/s12325-010-0059-9 - DOI - PubMed
    1. Musso CG (2004) Potassium metabolism in patients with chronic kidney disease. Part II: patients on dialysis (stage 5). Int Urol Nephrol 36(3):469–472 - DOI
    1. Vaziri ND (2016) Effect of synbiotic therapy on gut-derived uremic toxins and the intestinal microbiome in patients with CKD. Clin J Am Soc Nephrol 11(2):199–201 - DOI

Substances

LinkOut - more resources